Editorial
How to deal with steroids use in the management of metastatic prostate cancer during pandemic
Translational Andrology and Urology
2020;
9
(4)
:1546-1549
.
(25 August 2020)
Original Article
Effect of upregulation of DD3 on early detection and prognosis in prostate cancer
Translational Andrology and Urology
2020;
9
(4)
:1550-1558
.
(25 August 2020)
Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot- assisted laparoscopic prostatectomy
Translational Andrology and Urology
2020;
9
(4)
:1559-1565
.
(25 August 2020)
The clinical application of enhanced recovery after surgery protocol in perioperative period of laparoscopic nephron sparing surgery
Translational Andrology and Urology
2020;
9
(4)
:1566-1571
.
(25 August 2020)
Quantitative proteomic analysis of urinary exosomes in kidney stone patients
Translational Andrology and Urology
2020;
9
(4)
:1572-1584
.
(25 August 2020)
MicroRNA expression profile in the spinal cord injured rat neurogenic bladder by next-generation sequencing
Translational Andrology and Urology
2020;
9
(4)
:1585-1602
.
(25 August 2020)
Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEP
Translational Andrology and Urology
2020;
9
(4)
:1603-1610
.
(25 August 2020)
Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study
Translational Andrology and Urology
2020;
9
(4)
:1611-1629
.
(25 August 2020)
Aberrant integrin αv and α5 expression in prostate adenocarcinomas and bone-metastases is consistent with a bone-colonizing phenotype
Translational Andrology and Urology
2020;
9
(4)
:1630-1638
.
(25 August 2020)
The inflammation patterns of different inflammatory cells in histological structures of hyperplasic prostatic tissues
Translational Andrology and Urology
2020;
9
(4)
:1639-1649
.
(25 August 2020)
High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1650-1660
.
(25 August 2020)
Experience of diagnosis and management of metanephric adenoma: retrospectively analysis of 10 cases and a literature review
Translational Andrology and Urology
2020;
9
(4)
:1661-1669
.
(25 August 2020)
Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis
Translational Andrology and Urology
2020;
9
(4)
:1670-1677
.
(25 August 2020)
The impact of insurance status on the survival outcomes of patients with renal cell carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1678-1690
.
(25 August 2020)
The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials
Translational Andrology and Urology
2020;
9
(4)
:1691-1699
.
(25 August 2020)
Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
Translational Andrology and Urology
2020;
9
(4)
:1700-1711
.
(25 August 2020)
Berberine alleviates cisplatin-induced acute kidney injury by regulating mitophagy via PINK 1/Parkin pathway
Translational Andrology and Urology
2020;
9
(4)
:1712-1724
.
(25 August 2020)
The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1725-1734
.
(25 August 2020)
A new method to quantify penile erection hardness: real-time ultrasonic shear wave elastography
Translational Andrology and Urology
2020;
9
(4)
:1735-1742
.
(25 August 2020)
Review Article
Clinical efficacy and safety of enhanced recovery after surgery for patients treated with radical cystectomy and ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials
Translational Andrology and Urology
2020;
9
(4)
:1743-1753
.
(25 August 2020)
Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review
Translational Andrology and Urology
2020;
9
(4)
:1754-1768
.
(25 August 2020)
Case Report
Deep vein thrombosis in a nonobstructive azoospermia male taking tamoxifen: a rare case report
Translational Andrology and Urology
2020;
9
(4)
:1769-1772
.
(25 August 2020)
Bartholin gland cyst in a transgender male: case report of a rare occurrence
Translational Andrology and Urology
2020;
9
(4)
:1773-1777
.
(25 August 2020)
Editorial on Upper-Tract Urothelial Carcinoma: Current State and Future Directions1
An editorial comment for the special series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions”
Translational Andrology and Urology
2020;
9
(4)
:1778-1779
.
(25 August 2020)
Original Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions1
Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy
Translational Andrology and Urology
2020;
9
(4)
:1780-1785
.
(25 August 2020)
Incidence and preoperative predictors for major complications following radical nephroureterectomy
Translational Andrology and Urology
2020;
9
(4)
:1786-1793
.
(25 August 2020)
Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions1
Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1794-1798
.
(25 August 2020)
Risk stratification for upper tract urinary carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1799-1808
.
(25 August 2020)
Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
Translational Andrology and Urology
2020;
9
(4)
:1809-1814
.
(25 August 2020)
Endoscopic management of upper tract urothelial carcinoma—tips and tricks
Translational Andrology and Urology
2020;
9
(4)
:1815-1820
.
(25 August 2020)
Outcomes of endoscopic management of upper tract urothelial carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1821-1830
.
(25 August 2020)
Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1831-1840
.
(25 August 2020)
Oncologic outcomes of radical nephroureterectomy (RNU)
Translational Andrology and Urology
2020;
9
(4)
:1841-1852
.
(25 August 2020)
Perioperative complications and adverse sequelae of radical nephroureterectomy
Translational Andrology and Urology
2020;
9
(4)
:1853-1859
.
(25 August 2020)
The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
Translational Andrology and Urology
2020;
9
(4)
:1860-1867
.
(25 August 2020)
Controversies in management of the bladder cuff at nephroureterectomy
Translational Andrology and Urology
2020;
9
(4)
:1868-1880
.
(25 August 2020)
Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
Translational Andrology and Urology
2020;
9
(4)
:1881-1890
.
(25 August 2020)
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
Translational Andrology and Urology
2020;
9
(4)
:1891-1896
.
(25 August 2020)
Disclosure:
1. The series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. John J. Knoedler and Jay D. Raman served as the unpaid Guest Editors for the series.
